ロード中...
Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
BACKGROUND: Plasminogen activator inhibitor 1 (PAI-1) was previously established to impact several phenotypes in many kinds of cancer, including pancreatic cancer. However, its prognostic significance in pancreatic ductal adenocarcinoma (PDAC) needs support of further evidence. This study was design...
保存先:
| 出版年: | Chin Med J (Engl) |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6302640/ https://ncbi.nlm.nih.gov/pubmed/30539907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.247211 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|